NCT02686424View on ClinicalTrials.gov

Tumor Markers Study in Gastric Cancer for Cancer Immunotherapy (ONCO-RD 010 CRT)

SuspendedOBSERVATIONAL
Enrollment

250

Participants

Timeline

Start Date

March 31, 2010

Primary Completion Date

January 31, 2015

Conditions
Stomach Neoplasms
Sponsors

Collaborators (1)

GlaxoSmithKline
All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

lead

Seoul National University Hospital

OTHER

NCT02686424 - Tumor Markers Study in Gastric Cancer for Cancer Immunotherapy (ONCO-RD 010 CRT) | Biotech Hunter | Biotech Hunter